In 2022, the FDA licensed tirzepatide for T2D therapy beneath the brand name identify Mounjaro dependant on the SURPASS software effects, which demonstrated a discount of around -3.02% in glycated hemoglobin. It is administered in weekly doses of approximately 15mg [one, thirty]. Tirzepatide has als